Clinical Trial Diversity: An Affective Trust Framework for Engaging & Recruiting Communities of Color

Key Takeaways and Learnings Underrepresentation slows recruitment, increases dropout risk, and weakens data reliability. Proactive inclusion strategie...

In clinical research, data is everything. It’s the foundation of scientific discovery, the evidence behind regulatory approvals, and the key to develo...

Key Takeaways and Learnings Traditional “one-size-fits-all” recruitment fails to address the barriers and concerns of underrepresented communities. Or...

Key Takeaways and Learnings Over the past few years, FDA diversity guidance has recommended early, structured inclusion planning. Despite shifting pol...

In healthcare, we often hear terms like community outreach and community engagement used interchangeably. They sound similar—both involve connecting w...

Key Takeaways and Learnings Building trust in clinical trials requires early, sustained community engagement—not just recruitment outreach. Historical...

Key Takeaways and Learnings Health equity solutions must be rooted in community-informed design, not top-down assumptions. Building trust requires ong...

Key Takeaways and Learnings The recent FDA diversity in clinical trials guidance emphasizes how sponsors plan on reaching specific representation goal...

Key Takeaways and Learnings Representation is so much more than just showing up. Performative inclusion weakens trust and risks perpetuating dispariti...